Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $5.62M | $5.52M | $7.98M | $7.23M |
| Revenue growth | — | -1.8% | 44.7% | -9.5% |
| Gross profit | $1.06M | $1.41M | $1.65M | $2.49M |
| Gross margin | 18.9% | 25.6% | 20.7% | 34.4% |
| Operating income | -$2.09M | -$2.89M | -$3.76M | -$904K |
| Operating margin | -37.2% | -52.4% | -47.2% | -12.5% |
| Net income | -$2.12M | -$2.94M | -$3.76M | -$896K |
| Net margin | -37.7% | -53.3% | -47.1% | -12.4% |
| EPS (diluted) | -$0.70 | -$0.60 | -$0.50 | -$0.08 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$2.24M | -$2.76M | -$2.93M | -$448K |
| Capital expenditures | $121K | $15.3K | $11.1K | $107.00 |
| Free cash flow | -$2.37M | -$2.77M | -$2.94M | -$448K |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $3.34K | $3.28M | $2.40M | $1.61M |
| Total assets | $2.32M | $4.92M | $3.68M | $2.77M |
| Total liabilities | $1.61M | $910K | $801K | $675K |
| Shareholders' equity | $710K | $4.01M | $2.88M | $2.10M |
| Retained earnings | -$2.13M | -$5.06M | -$8.82M | -$9.72M |
| Shares (wtd avg diluted) | 3.04M | 4.88M | 7.55M | 11.9M |
Every figure is extracted from Syra Health Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.